Besremi (Ropeginterferon

Besremi (Ropeginterferon alfa-2b-njft)

Besremi

Ropeginterferon alfa-2b-njft

Injection: 500 mcg/mL solution in a single-dose prefilled syringe

PharmaEssentia Corporation

Medical Use

Besremi is an interferon alfa-2b medication used to treat adults with polycythemia vera, a condition characterized by the excessive production of red blood cells.

Recommended Dosage: Start with 100 mcg administered subcutaneously every two weeks (or 50 mcg if the patient is also taking hydroxyurea). Gradually increase the dose by 50 mcg every two weeks, up to a maximum of 500 mcg, until blood parameters stabilize. If certain adverse reactions occur, dosing should be interrupted or discontinued.